| Literature DB >> 24294136 |
A W Tekeleselassie1, Y M Goh, M A Rajion, M Motshakeri, M Ebrahimi.
Abstract
This study was aimed to investigate the effects of dietary fatty acids on the accretion pattern of major fat pads, inguinal fat cellularity, and their relation with plasma leptin concentration. Forty Sprague-Dawley rats were randomly assigned into four groups and received the following diets for 22 weeks: (1) standard rat chow diet (CTRL), (2) CTRL + 10% (w/w) butter (HFAR), (3) CTRL + 3.33% (w/w) menhaden fish oil + 6.67% (w/w) soybean oil (MFAR), and (4) CTRL + 6.67% (w/w) menhaden fish oil + 3.33% (w/w) soybean oil (LFAR). Inguinal fat cellularity and plasma leptin concentration were measured in this study. Results for inguinal fat cellularity showed that the mean adipocyte number for the MFAR (9.2 ∗ 10⁵ ± 3.6) and LFAR (8.5 ∗ 10⁵ ± 5.1) groups was significantly higher (P < 0.05) than the rest, while the mean adipocyte diameter of HFAR group was larger (P < 0.05) (46.2 ± 2.8) than the rest. The plasma leptin concentration in the HFAR group was higher (P < 0.05) (3.22 ± 0.32 ng/mL), than the other groups. The higher inguinal fat cellularity clearly indicated the ability of the polyunsaturated fatty acids (PUFA) and butter supplemented diets to induce hyperplasia and hypertrophy of fat cells, respectively, which caused adipocyte remodeling due to hyperleptinemia.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24294136 PMCID: PMC3833013 DOI: 10.1155/2013/757593
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Chemical constituents of the standard chow diet (dry-weight basis).
| Constituents (per 100 g feed) | Diet |
|---|---|
| Crude fat (g) | 3 |
| Crude protein (g) | 20 |
| Carbohydrate (g) | 51 |
| Crude fiber (g) | 7.3 |
| Ash (g) | 9.2 |
| Calcium | 0.9 |
| Phosphorus | 0.5 |
Plasma fatty acid profile of treatment groups.
| Fatty acid (g/100 ml) | Experimental diets | ||||
|---|---|---|---|---|---|
| Name | CTRL | HFAR | MFAR | LFAR | SEM |
| Capric acid (10:0) | n/d | n/d | 0.5a | 0.5a | 0.14 |
| Lauric acid (12:0) | n/d | 0.3a | 0.2a | 0.3a | 0.07 |
| Myristic acid (14:0) | 0.5a | 0.7ab | 0.7bc | 1.0c | 0.10 |
| Pentadecanoic acid (15:0) | 0.6ab | 0.5a | 0.7ab | 0.8b | 0.06 |
| Palmitic acid (16:0) | 18.1ab | 19.9b | 16.6a | 19.0ab | 0.70 |
| Palmitoleic acid (16:1) | 0.7a | 0.5a | 1.2b | 1.2b | 0.18 |
| Heptadecanoic acid (17:0) | 0.6a | 0.5a | 0.7ab | 0.9b | 0.09 |
| Stearic acid (18:0) | 11.7ab | 12.4b | 11.2a | 10.4a | 0.42 |
| Oleic acid (18:1) | 9.9a | 12.3a | 13.2a | 11.2a | 0.71 |
| Linoleic acid (18:2(n-6)) | 22.3a | 19.3a | 23.8a | 24.3a | 1.13 |
| Linolenic acid (18:3(n-3)) | 0.4 | n/d | n/d | 0.01 | 0.01 |
| Arachidic acid (20:0) | 0.8b | 0.4a | 0.7b | 0.9b | 0.11 |
| Cis-11-Eicosenoic (20:1) | 0.4a | 0.6ab | 0.4a | 0.8b | 0.10 |
| Cis-11,14,17-Eicosatrienoic (20:3) | 0.5a | 0.5ab | 0.7b | n/d | 0.15 |
| Arachidonic acid (20:4(n-6)) | 30.9b | 28.9b | 20.1a | 14.6a | 1.81 |
| Eicosapentaenoic acid (20:5(n-3)) | n/d | n/d | 2.5a | 5.4b | 1.28 |
| Behenic acid (22:0) | 0.8a | 1.5b | 1.6ab | 1.5ab | 0.18 |
| Docosapentaenoic acid (22:5(n-3)) | n/d | n/d | 0.6a | 1.1b | 0.27 |
| Docosahexanoic acid (22:6(n-3)) | 2.0a | 1.8a | 4.6b | 6.4b | 0.10 |
| Total saturated fatty acidsns | 33.0 | 36.2 | 33.0 | 35.3 | 0.82 |
| Total unsaturated fatty acidsns | 67.0 | 63.8 | 67.0 | 64.7 | 0.82 |
| Total monounsaturated fatty acidsns | 11.0 | 13.4 | 14.7 | 13.2 | 0.79 |
| Total PUFA n-3 | 2.4a | 1.8a | 7.7b | 12.91c | 0.60 |
| Total PUFA n-6 | 53.2b | 48.7b | 43.9ab | 38.9a | 3.05 |
| n-6 : n-3 ratio | 22.17b | 34.1b | 5.7a | 3.02a | 1.91 |
| U : S rations | 2.0 | 1.8 | 2.04 | 1.8 | 0.07 |
| P : S ratio | 1.7c | 1.4a | 1.6bc | 1.5ab | 0.06 |
a,b,cValues with different superscripts within rows are significantly different (P < 0.05); n/d: not detected; S: saturated; U: unsaturated; P: polyunsaturated; nsnot significant. SEM: standard error of means.
CTRL: control group; HFAR: high n-6 : n-3 fatty acid ratio group; MFAR: medium n-6 : n-3 fatty acid ratio group; LFAR: low n-6 : n-3 fatty acid ratio group.
Body composition, fat accretion, and inguinal fat cellularity of rats (Mean ± SEM).
| Treatment groups | CTRL | HFAR | MFAR | LFAR |
|---|---|---|---|---|
| Live weight (g) | 456.9 ± 10.6a | 510.6 ± 13.2b | 511.8 ± 15.0b | 502.50 ± 17.0b |
| Actual carcass Weight (g) | 291.6 ± 8.6a | 333.8 ± 8.7b | 330.1 ± 10.4b | 311.5 ± 11.3ab |
| Total muscle (g) | 187.1 ± 5.1a | 207.5 ± 5.6b | 208.2 ± 5.6b | 195.8 ± 7.9ab |
| Inguinal fat (g) | 10.64 ± 1.29a | 17.14 ± 1.40b | 13.98 ± .98ab | 14.12 ± 1.38ab |
| Retroperitoneal fat (g) | 6.67 ± 1.05a | 12.16 ± 0.90b | 10.67 ± 1.02b | 9.51 ± 1.02ab |
| Mesenteric fat (g) | 4.46 ± 0.49a | 6.31 ± 0.51b | 6.89 ± 0.64b | 6.61 ± 0.42b |
| Epididymal fat (g) | 5.67 ± 0.61a | 7.99 ± 0.72b | 7.71 ± .77b | 6.33 ± 0.49ab |
| Anterior fat (g) | 12.9 ± 1.6a | 17.8 ± 1.5b | 16.1 ± 1.0ab | 14.9 ± 0.9ab |
| Total visceral fat (g) | 18.4 ± 2.3a | 29.0 ± 2.0b | 27.6 ± 2.5b | 24.4 ± 1.8ab |
| Total subcutaneous fat (g) | 23.5 ± 2.9a | 34.8 ± 2.8b | 30.1 ± 1.8ab | 29 ± 2.2ab |
| Total fat (g) | 41.9 ± 5.0a | 63.8 ± 4.7b | 57.7 ± 4.0b | 53.4 ± 3.9ab |
| Fat to lean mass ratio | 0.22 ± 0.04a | 0.31 ± 0.02b | 0.28 ± 0.02ab | 0.27 ± 0.02ab |
| Adipocyte number ∗ 105/g | 7.2 ± 3.3a | 6.7 ± 4.6a | 9.2 ± 3.6b | 8.5 ± 5.1b |
| Adipocyte diameter ∗ 106
| 30.6 ± 1a | 46.2 ± 2.8b | 35.1 ± 3.8a | 37.3 ± 1.8a |
a,bValues with different superscripts within rows are significantly different at P < 0.05. CTRL: Control group; HFAR: High n-6: n-3 fatty acid ratio group; MFAR: Medium n-6: n-3 fatty acid ratio group; LFAR: Low n-6: n-3 fatty acid ratio group.
Figure 1Plasma leptin concentration of rats in the four treatment groups. a, bDifferent letters among groups indicate significant difference at P < 0.05.